Docu Liquid

Product NDC: 17856-0771
11-digit product format: 178560771
Labeler code: 17856
Product ID: 17856-0771_3b3f3045-55db-5ed5-e063-6294a90aab75
Type: HUMAN OTC DRUG
Nonproprietary name: Docusate Sodium
Dosage form: LIQUID
Route: ORAL
Labeler: ATLANTIC BIOLOGICALS CORP.
Application: M
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 1997-08-01
Substance: DOCUSATE SODIUM
Active strength: 50 mg/5mL
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	17856-0771	17856-0771-1	D	Discontinued by firm		2026-08-11
excluded package	package	17856-0771	17856-0771-2	D	Discontinued by firm		2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 19 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0771-2	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0771-1	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0771-2	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0771-1	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-0771-2	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-0771-1	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-0771-2	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-0771-1	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	17856-0771-2	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	17856-0771-1	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	17856-0771-2	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	17856-0771-1	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	17856-0771-2	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	17856-0771-1	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`

Additional Listing Data#

Finished product: Yes
Brand name base: Docu Liquid
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DOCUSATE SODIUM	50 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
F05Q2T2JA0	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1248119	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
f4ed0721-3be9-4108-a6c9-dbbe115249e9	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
17856-0771-1	2024-05-24	Drug Facts
17856-0771-2	2024-05-24	Drug Facts
17856-0771-1	2022-01-28	Drug Facts
17856-0771-2	2022-01-28	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
17856-0771-1	Docu Liquid	50 in 1 BOX, UNIT-DOSE	LIQUID	50	3
17856-0771-1	Docu Liquid	25 mL in 1 CUP, UNIT-DOSE	LIQUID	25	3
17856-0771-2	Docu Liquid	10 mL in 1 CUP, UNIT-DOSE	LIQUID	10	3
17856-0771-2	Docu Liquid	72 in 1 BOX, UNIT-DOSE	LIQUID	72	3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
17856-0771-2	ML - Milliliter	17856-0771	c48e96da-0bd0-41c4-8dbf-13b1c32d8db9	1	2022-09-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17856-0771	DOCU LIQUID (DOCUSATE SODIUM) LIQUID [ATLANTIC BIOLOGICALS CORP.]	2	Current NDC, Legacy NDC, 4 package rows	20240526_f4ed0721-3be9-4108-a6c9-dbbe115249e9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 6 · 111 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MG DermaSpray 70	ETHYL ALCOHOL	Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc.	153ed8ff-5632-4f21-84de-2b87ac2bef31	2026-08-04	Warnings	Exact identifier application number: M
The Original Mane n Tail Daily Control 2 in 1 Anti Dandruff	PYRITHIONE ZINC	Straight Arrow Products Inc	68ab55d6-b1a9-46c0-87f0-ec12ad3474bc	2026-07-09	Warnings	Exact identifier application number: M
Stool Softener Laxative	DOCUSATE SODIUM	ATLANTIC BIOLOGICALS CORP.	c1f588d0-4600-4b97-b2d3-2c08ac351e07	2026-06-30	Warnings	Exact identifier application number: M
Docusate Sodium	DOCUSATE SODIUM	PD-Rx Pharmaceuticals, Inc.	66ca7a94-378b-4476-8060-d9c6f82f57fc	2026-06-12	Warnings	Exact identifier application number: M
TRIBIOTIC	BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	HART Health	3d17aba0-220f-42c4-9e26-5c44857847cd	2026-05-20	Warnings, Adverse reactions	Exact identifier application number: M
IT Cosmetics Your Skin But Better CC Plus Color Correcting Broad Spectrum SPF 50 Plus Sunscreen Full Coverage Deep Deep Honey Deep Bronze Neutral Deep Deep Mocha Tan Cool Rich Cool Deep Cool Neutral Rich	HOMOSALATE, OCTISALATE AND OCTOCRYLENE	LOreal USA Products Inc	2a44a019-0cc0-439b-aaa5-37582ec5492e	2026-05-14	Warnings	Exact identifier application number: M
THORACOL	HONEY LEMON COUGH DROPS	HART Health	fee9f594-c619-4d77-bb52-632078e0254e	2026-04-16	Warnings	Exact identifier application number: M
First Aid and Burn	BENZALKONIUM CHLORIDE, LIDOCAINE	HART Health	07d447f1-469c-4e34-b807-ede9a449e6ab	2026-04-15	Warnings	Exact identifier application number: M
HYDROCORTISONE	HYDROCORTISONE CREAM	HART Health	c76fb030-cbb5-4773-aa52-d038cb41d0af	2026-04-15	Warnings	Exact identifier application number: M
Hydrogen Peroxide	HYDROGEN PEROXIDE	Amazon.com Services LLC	55b0d905-fcc0-40ba-a5dd-331a27a3a209	2026-04-07	Warnings, Adverse reactions	Exact identifier application number: M
Docusate Sodium	DOCUSATE SODIUM 100MG	Pharbest Pharmaceuticals, Inc.	025e03e0-e273-47ed-87f7-98e388abe047	2026-03-05	Warnings	Exact identifier application number: M
TEENY TUMMY Gas Relief Drops	SIMETHICONE	ALTANTIC BIOLOGICAS CORP.	05eadb73-4468-4dae-a67b-133d893feed2	2026-02-13	Warnings	Exact identifier application number: M
Relief-PE	ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE	HART Health	9475fb51-931b-4a89-be6b-62e715d0883e	2026-01-15	Warnings	Exact identifier application number: M
ASPIRIN	ASPIRIN	HART Health	a1c73edf-861d-478b-9d3c-0eddcc6879cc	2026-01-14	Warnings	Exact identifier application number: M
HISTAPRIN	DIPHENHYDRAMINE	NorMed	38786a65-a12b-4479-b63c-b7c15410da04	2026-01-14	Warnings	Exact identifier application number: M
Blood Clotting	BENZETHONIUM CHLORIDE AND LIDOCAINE	HART Health	21668731-8b8a-404f-80ab-962a0a9d5f63	2026-01-14	Warnings	Exact identifier application number: M
Bandage	BENZOCAINE AND BENZETHONIUM CHLORIDE	HART Health	6de57472-6dd0-43b6-8a82-fe459fa99ddb	2026-01-14	Warnings	Exact identifier application number: M
Sooth-a-Sting	BENZOCAINE, ISOPROPYL ALCOHOL	HART Health	c0e7d661-a9c9-4656-a516-57552848ebe8	2026-01-12	Warnings	Exact identifier application number: M
Alcohol	ISOPROPYL ALCOHOL	HART Health	8d01b10b-7916-420e-9d44-ebd3806fe315	2026-01-12	Warnings	Exact identifier application number: M
Eye Clean	EYE WASH	HART Health	41f53e2e-c2bc-4bf1-a541-3bcb2cf63002	2025-12-31	Warnings	Exact identifier application number: M

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F05Q2T2JA0	DOCUSATE SODIUM	577-11-7	DOCUSATE SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1248119	docusate sodium 50 MG in 5 mL Oral Suspension	PSN	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 10 MG/ML Oral Suspension	SCD	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 100 MG per 10 ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 150 MG per 15 ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	docusate sodium 50 MG per 5 ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3
1248119	DOSS Sodium 10 MG/ML Oral Suspension	SY	f4ed0721-3be9-4108-a6c9-dbbe115249e9	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
17856-0771-1	17856077101	50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0771-1) > 25 mL in 1 CUP, UNIT-DOSE	2020-01-31	0000-00-00	No	No	Current
17856-0771-2	17856077102	72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0771-2) > 10 mL in 1 CUP, UNIT-DOSE	2020-01-31	0000-00-00	No	No	Current